Related Experiment Video
Updated: Feb 20, 2026

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal
Patrick Ming-Kuen Tang1, Shuang Zhou2, Chun-Jie Li3
1Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, and Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Abstract:
Src activation has been associated with fibrogenesis after kidney injury. Macrophage-myofibroblast transition is a newly identified process to generate collagen-producing myofibroblasts locally in the kidney undergoing fibrosis in a TGF-β/Smad3-dependent manner. The potential role of the macrophage-myofibroblast transition in Src-mediated renal fibrosis is unknown. In studying this by RNA sequencing at single-cell resolution, we uncovered a unique Src-centric regulatory gene network as a key underlying mechanism of macrophage-myofibroblast transition. A total of 501 differentially expressed genes associated with macrophage-myofibroblast transition were identified. However, Smad3-knockout largely reduced the transcriptome diversity. More importantly, inhibition of Src largely suppresses ureteral obstruction-induced macrophage-myofibroblast transition in the injured kidney in vivo along with transforming growth factor-β1-induced elongated fibroblast-like morphology, α-smooth muscle actin expression and collagen production in bone marrow derived macrophages in vitro. Unexpectedly, we further uncovered that Src serves as a direct Smad3 target gene and also specifically up-regulated in macrophages during macrophage-myofibroblast transition. Thus, macrophage-myofibroblast transition contributes to Src-mediated tissue fibrosis. Hence, targeting Src may represent as a precision therapeutic strategy for macrophage-myofibroblast transition-driven fibrotic diseases.
Insights
Src activation drives kidney fibrosis through macrophage-myofibroblast transition. Targeting Src may offer a precision therapy for fibrotic diseases by inhibiting this pathway.
Area of Science:
- Cell Biology
- Renal Physiology
- Molecular Medicine
Background:
- Src activation is linked to kidney fibrogenesis.
- Macrophage-to-myofibroblast transition (MMT) generates collagen-producing cells in fibrotic kidneys via TGF-β/Smad3.
- The role of MMT in Src-mediated renal fibrosis remains unclear.
Purpose of the Study:
- To investigate the role of MMT in Src-mediated renal fibrosis.
- To identify the regulatory mechanisms underlying MMT.
- To explore Src as a therapeutic target for MMT-driven fibrotic diseases.
Main Methods:
- Single-cell RNA sequencing to identify differentially expressed genes during MMT.
- In vivo studies using ureteral obstruction model.
- In vitro studies using bone marrow-derived macrophages stimulated with TGF-β1.
- Smad3 knockout models.
Main Results:
- A Src-centric gene network regulating MMT was identified, with 501 differentially expressed genes.
- Smad3 knockout reduced transcriptome diversity.
- Src inhibition suppressed MMT in vivo and TGF-β1-induced MMT in vitro, including fibroblast-like morphology, α-smooth muscle actin expression, and collagen production.
- Src is a direct Smad3 target gene and is upregulated in macrophages during MMT.
Conclusions:
- MMT contributes to Src-mediated renal fibrosis.
- Src acts as a key regulator in the MMT process.
- Targeting Src presents a potential precision therapeutic strategy for fibrotic diseases driven by MMT.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
TGF - β Signaling Pathway
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

